Aleafia Health Launches Cannabis 2.0 Portfolio with 510 Vape Cartridges Featuring Unique Formulations

• Vape launch represents the first of a broader expansion of the Company’s product portfolio
• Rollout of further innovative Cannabis 2.0 formats in near term with production of cannabis-infused sublingual strips and confectionary edibles underway
• New 2.0 formats to be coupled with a bolstered dried flower offering, featuring new cultivars and greater SKU availability

TORONTO, September 29, 2020 – Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce the launch and release of 510 vape cartridges which represent the Company’s first Cannabis 2.0 product format in market.

“This is an important milestone which represents just the first step in our entering the adult-use market in a meaningful way, while strengthening our expanding medical cannabis market share. We look forward to an exciting sequence of product launches in the months ahead, as we continue to bring new innovative formats to market, while expanding our core portfolio,” said Aleafia Health CEO Geoffrey Benic.

Expanded Product Portfolio Highlights

• 510 Vape Cartridges: Sold under the Symbl^TM adult-use and Emblem^TM medical brands, the vapes are inspired by Aleafia Health’s signature cultivars. The custom-made, unique terpene blends deliver robust flavours and consistent effects. They contain CO2-extracted distillate mixed with a custom blend of botanically sourced terpenes. No fillers or artificial flavours are used, offering consumers and patients an authentic experience.
• Sublingual Strips: Full production and packaging of the first production lot of cannabis-infused sublingual strips is underway, with a near-term launch expected. Featuring a rapid onset time and novel form factor, the sublingual strips offer patients and consumers a discreet, consistent experience.
• Confectionary Edibles: Initial production of confectionary edibles has also begun at the Company’s Paris Facility following extensive research & development. They represent a major growth format with limited availability in Canada to date.
• Expanded Dried Flower Offering: Expanding upon its signature strains, the Company has acquired a roster of new cultivars that are now in production at the Niagara Facility. Leveraging the greater scale of cultivation at Niagara, the Company will begin introducing a broader assortment of dried flower SKUs to align with the demand of key consumer segments.

Nicholas Bergamini, VP Investor Relations
1-833-879-2533
IR@AleafiaHealth.com
LEARN MORE: www.AleafiaHealth.com

About Aleafia Health:

Aleafia Health is a vertically integrated and federally licensed Canadian cannabis company offering cannabis health and wellness services and products in Canada and in international markets. The Company operates medical clinics, education centres and production facilities for the production and sale of cannabis.

Aleafia Health owns three significant licensed cannabis production facilities, including the first large-scale, legal outdoor cultivation facility in Canadian history. The Company produces a diverse portfolio of commercially proven, high-margin derivative products including oils, capsules and sprays. Aleafia Health operates the largest national network of medical cannabis clinics and education centres staffed by MDs, nurse practitioners and educators and operates internationally in three continents.

Innovation, the heart of Aleafia Health’s competitive advantage, has led to the Company maintaining a medical cannabis dataset with over 10 million data points to inform proprietary illness-specific product development and its highly differentiated education platform FoliEdge Academy. The Company is committed to creating sustainable shareholder value; the TSX Venture Exchange named Aleafia the 2019 top performing company prior to its graduation to the TSX.

Forward Looking Information

This news release contains forward-looking information within the meaning of applicable Canadian and United States securities laws. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes” or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved.

Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company or its subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including risks contained in the Company’s annual information form filed with Canadian securities regulators available on the Company’s SEDAR profile at www.sedar.com. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company does not undertake any obligation to publicly update such forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.